Table 2 Baseline characteristics of females subjects
From: The association between liver enzymes and risk of type 2 diabetes: the Namwon study
Variables | Females (n = 4,323) | ||
|---|---|---|---|
Diabetes ‡ | Non-diabetes | p-value* | |
Age (years) | 61.7 (6.9) | 60.8 (7.7) | 0.049 |
Body mass index (kg/m2) | 26.1 (3.9) | 24.5 (3.2) | <0.001 |
Waist circumference (cm) | 89.3 (8.7) | 85.8 (8.7) | <0.001 |
AST (units/l) | 23 (19–27) | 22 (19–26) | 0.076 |
ALT (units/l) | 20 (14–26) | 16 (13–21) | <0.001 |
GGT (units/l) | 20 (15–31) | 15 (12–21) | <0.001 |
Fasting glucose (mg/dl) | 106.8 (9.6) | 96.5 (9.2) | <0.001 |
HOMA (%) | 1.74 (1.05) | 1.31 (0.96) | <0.001 |
Total cholesterol (mg/dl) | 200.2 (36.2) | 192.9 (36.7) | 0.001 |
HDL cholesterol (mg/dl) | 45.8 (10.9) | 48.6 (11.7) | <0.001 |
Triglycerides (mg/dl) | 161 (113–243.5) | 123 (86–177) | <0.001 |
C-reactive protein (mg/dl) | 0.09 (0.04-0.20) | 0.05 (0.02-0.11) | 0.444 |
Current drinker (%) | 109 (34.8) | 1,454 (36.3) | 0.112 |
Current smoker (%) | 11 (3.5) | 110 (2.7) | 0.317 |
Physical exercise (%) | 100 (31.9) | 1,242 (31.0) | 0.730 |